The Parker Institute, Frederiksberg Hospital
Frederiksberg, 2000, Denmark
NCT Number: NCT00938808
Obesity and osteoarthritis (OA) co-exist in an increasing part of the population.
The two diseases intertwine in several ways. The evolution in the population shows a tendency towards deterioration of both by increasing general age and weight. The two diseases share pathogenetic features and the development of one disease increases the risk of the other and may be the onset of a vicious circle.
There is a link between treatments of these two diseases as well. There is now solid (gold) evidence that by treating effectively the obesity of patients with co-occurring OA, the functional status is dramatically ameliorated; the short-term results are equal to that of a joint replacement. The long-term efficacy of a weight loss remains to be shown. OA is definitely one of many diseases in which obesity must be taken seriously into account when planning a correct treatment of patients. This trial is an extension of the former CAROT trial NCT00655941. The participants of this trial are recruited for a prolongation of the dietary intervention consisting of a group therapy with low-energy diet in a randomized, two group (each n = 75 patients) study of maintenance of weight loss by continuing with supplementary either 3 x 5 weeks dietary supplements only or once-daily supplement. The hypothesis is that maintenance of the already induced weight loss is most efficiently ensured by the once-daily program.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Frederiksberg, 2000, Denmark
Any patient with osteoarthritis (OA) of the knee was invited to participate in the preceding trial. Eligible for this study will be patients, who have completed the one-year phase 2 of the CAROT. Exclusion criteria are planned knee alloplasty of both knees.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Former participant in the CAROT study ( NCT00655941 )
-
Exclusion criteria
Bilateral knee alloplasty -
The Cambridge Programme. Formula diet
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Time frame: 1 year, 3 years
Henning Bliddal
Other
Acronym: LIGH T
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00655941
Arthritis, Behavior
Frederiksberg, Denmark
View Trial DetailsNCT05349500
Arthritis, Behavior
Chapel Hill, North Carolina, United States
View Trial DetailsNCT01469403
Arthritis, Body Weight
Aarhus, Denmark
View Trial DetailsNCT06191848
Arthritis, Body Weight
Fitzroy, Victoria, Australia
View Trial Details